申请人:GlaxoSmithKline Intellectual Property Development Limited
公开号:US20220112174A1
公开(公告)日:2022-04-14
This invention relates to novel compounds according to Formula (I) which are antagonists of MrgX2, to pharmaceutical compositions containing them, and to their use in therapy for the treatment of MrgX2-mediated diseases and disorders.
Understanding and Controlling the Mizoroki–Heck Reaction of Cyclic Enones
作者:Aishabibi Kassymbek、Francisco José Aguilar Troyano、Victoria Dimakos、Daniel P. Canterbury、Sebastien Monfette、Philipp C. Roosen、Stephen G. Newman
DOI:10.1021/acscatal.4c00854
日期:2024.6.7
Pd-catalyzed Mizoroki–Heckreactions using cyclohexenone and related cyclic enones are surprisingly difficult, contrasting related reactions with acyclic-conjugated alkenes. In this report, we uncover several challenges associated with the reaction, including the decomposition of the starting materials and products during the reaction. Kinetic analysis, reaction optimization, and stoichiometric studies